BioPACIFIC MIP

Advances in synthetic biology are enabling the scalable and sustainable production of non-petroleum-based monomers and the identification of conditions that lead to economical in cellulo polymerization. Similarly, advances in synthetic chemistry now utilize a broad range of functional monomers in controlled polymer synthesis. The NSF BioPACIFIC MIP (DMR-1933487) aims to merge these new realities by providing access to scientific expertise, multiscale computation and simulation for forward and inverse design, physical bio-sourced monomer libraries and digital pathways libraries, and advanced instrumentation capabilities. BioPACIFIC enables data-driven discovery and scalable production of bio-derived building blocks and polymers from yeast, fungi and bacteria, and...

Materials,polymers,biomaterials,3d printing,automated chemistry,synthetic biology,saxs-waxd,and microed

Biopacific mip operates in the Research services industry.

Biopacific mip's revenue is 11m - 100m

Biopacific mip has 11 - 50 employees.